CoChat

Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers

Open access
Fraser, Kyle B., Moehle, Mark S., Alcalay, Roy N., West, Andrew B., LRRK2 Cohort Consortium, Bressman, Susan, Giladi, Nir, Marder, Karen, Marti Masso, Jose Felix, Tolosa, Eduardo, Aasly, Jan, Berg, Daniela, Gasser, Thomas, Brice, Alexis, Corvol, Jean-Christopher, Chan, Piu, Drabant, Emily, Foroud, Tatiana, Hentati, Faycal, Farrer, Matthew, Maras, Connie, Lang, Anthony, Schuele, Birgitt · 2016 · Neurology
Cited by 131

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To test whether phosphorylated Ser-1292 LRRK2 levels in urine exosomes predicts LRRK2 mutation carriers (LRRK2+) and noncarriers (LRRK2-) with Parkinson disease (PD+) and without Parkinson disease (PD-). METHODS: LRRK2 protein was purified from urinary exosomes collected from participants in 2 independent cohorts. The first cohort included 14 men (LRRK2+/PD+, n = 7; LRRK2-/PD+, n = 4; LRRK2-/PD-, n = 3). The second cohort included 62 men (LRRK2-/PD-, n = 16; LRRK2+/PD-, n = 16; LRRK2+/PD+, n = 14; LRRK2-/PD+, n = 16). The ratio of Ser(P)-1292 LRRK2 to total LRRK2 was compared between LRRK2+/PD+ and LRRK2- in the first cohort and between LRRK2 G2019S carriers with and without PD in the second cohort. RESULTS: LRRK2+/PD+ had higher ratios of Ser(P)-1292 LRRK2 to total LRRK2 than LRRK2-/PD- (4.8-fold, p < 0.001) and LRRK2-/PD+ (4.6-fold, p < 0.001). Among mutation carriers, those with PD had higher Ser(P)-1292 LRRK2 to total LRRK2 than those without PD (2.2-fold, p < 0.001). Ser(P)-1292 LRRK2 levels predicted symptomatic from asymptomatic carriers with an area under the receiver operating characteristic curve of 0.844. CONCLUSION: Elevated ratio of phosphorylated Ser-1292 LRRK2 to total LRRK2 in urine exosomes predicted LRRK2 mutation status and PD risk among LRRK2 mutation carriers. Future studies may explore whether interventions that reduce this ratio may also reduce PD risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000002436

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 131

Metadata

Authors
Fraser, K. B., Moehle, M. S., Alcalay, R. N., West, A. B., LRRK2 Cohort Consortium, Bressman, S., Giladi, N., Marder, K., Marti Masso, J. F., Tolosa, E., Aasly, J., Berg, D., Gasser, T., Brice, A., Corvol, J.-C., Chan, P., Drabant, E., Foroud, T., Hentati, F., Farrer, M., Maras, C., Lang, A., & Schuele, B.
Venue
Neurology
Published
2016-03-15
Volume
86
Issue
11
Pages
994-999
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2295939659
Cited by
131
References
2
FWCI
9.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers. https://app.cochat.ai/papers/10.1212/wnl.0000000000002436
The paper
Fraser, K. B., Moehle, M. S., Alcalay, R. N., West, A. B., LRRK2 Cohort Consortium, Bressman, S., Giladi, N., Marder, K., Marti Masso, J. F., Tolosa, E., Aasly, J., Berg, D., Gasser, T., Brice, A., Corvol, J.-C., Chan, P., Drabant, E., Foroud, T., Hentati, F., . . . Schuele, B. (2016). Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers. Neurology. https://doi.org/10.1212/wnl.0000000000002436

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.